Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Partial F8 gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia

Paolo Simioni, Stefano Cagnin, Francesca Sartorello, Gabriele Sales, Luca Pagani, Cristiana Bulato, Sabrina Gavasso, Francesca Nuzzo, Francesco Chemello, Claudia M. Radu, Daniela Tormene, Luca Spiezia, Tilman M. Hackeng, Elena Campello, Elisabetta Castoldi

Blood (2021) 137 (17): 2383–2393.

https://doi.org/10.1182/blood.2020008168

Published: 2021

Includes: Supplemental data

Journal Articles

Could Hemorrhagic and Thrombotic Risk Due to Peg-Asparaginase be Identified By Coagulative Tests Using Fibtem and Antithrombin Levels? A Single Centre Study

Elena Varotto, Giovanna Sanna, Luca Spiezia, Stefania Varotto, MD, Marta Pillon, MD, Laura Sainati, MD, Alessandra Todesco, Barbara Buldini, MD, Maria Grazia Petris, Raffaella Colombatti, Manuela Tumino, Giada Biddeci, Antonio Marzollo, Maria Gabelli, Maria Paola Boaro, Elena Campello, Paolo Simioni, MD PhD, Giuseppe Basso, Prof, MD, Maria Caterina Putti, MD

Blood (2015) 126 (23): 2305.

https://doi.org/10.1182/blood.V126.23.2305.2305

Published: 2015

Journal Articles

Antithrombin Plasma Levels and Fibtem Determination in Children with Acute Lymphoblastic Leukemia Undergoing Asparaginase Treatment

Giada Biddeci, Giovanna Sanna, Giulia Geranio, Stefania Varotto, MD, Elena Varotto, Maria Gabelli, Mariagrazia Petris, Sara Maggiolo, Elena Campello, Maria Bon, Paolo Simioni, Luca Spiezia, Sartori Maria Teresa, Giuseppe Basso, Maria Caterina Putti

Blood (2014) 124 (21): 5246.

https://doi.org/10.1182/blood.V124.21.5246.5246

Published: 2014

Journal Articles

Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation

Francesca Nuzzo, Claudia Radu, Marco Baralle, Luca Spiezia, Tilman M. Hackeng, Paolo Simioni, Elisabetta Castoldi

Blood (2013) 122 (23): 3825–3831.

https://doi.org/10.1182/blood-2013-04-499657

Published: 2013

Includes: Supplemental data

Journal Articles

Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms

Connie Duckers, Paolo Simioni, Luca Spiezia, Claudia Radu, Paolo Dabrilli, Sabrina Gavasso, Jan Rosing, Elisabetta Castoldi

Blood (2010) 115 (4): 879–886.

https://doi.org/10.1182/blood-2009-08-237719

Published: 2010

Journal Articles

Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency

Connie Duckers, Paolo Simioni, Luca Spiezia, Claudia Radu, Sabrina Gavasso, Jan Rosing, Elisabetta Castoldi

Blood (2008) 112 (9): 3615–3623.

https://doi.org/10.1182/blood-2008-06-162453

Published: 2008

Journal Articles

Isolation and Characterization of an Antifactor VIII Antibody from a Patient with Acquired Hemophilia A and a Severe Hemorrhagic Syndrome.

Michael A. Bukys, BS, Paolo Simioni, MD/Ph.D, Kerri Smith, BS, Luca Spiezia, Michael Kalafatis, Ph.D.

Blood (2006) 108 (11): 4073.

https://doi.org/10.1182/blood.V108.11.4073.4073

Published: 2006

NARROW

Partial F8 gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia

Could Hemorrhagic and Thrombotic Risk Due to Peg-Asparaginase be Identified By Coagulative Tests Using Fibtem and Antithrombin Levels? A Single Centre Study

Antithrombin Plasma Levels and Fibtem Determination in Children with Acute Lymphoblastic Leukemia Undergoing Asparaginase Treatment

Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation

Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms

Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency

Isolation and Characterization of an Antifactor VIII Antibody from a Patient with Acquired Hemophilia A and a Severe Hemorrhagic Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Partial F8 gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia

Could Hemorrhagic and Thrombotic Risk Due to Peg-Asparaginase be Identified By Coagulative Tests Using Fibtem and Antithrombin Levels? A Single Centre Study

Antithrombin Plasma Levels and Fibtem Determination in Children with Acute Lymphoblastic Leukemia Undergoing Asparaginase Treatment

Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation

Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms

Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency

Isolation and Characterization of an Antifactor VIII Antibody from a Patient with Acquired Hemophilia A and a Severe Hemorrhagic Syndrome.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only